AK
Andrew Krowne
OtherActiveManaging Director at Dolby Family Ventures
San Francisco, United StatesFounded 2020
56
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Andrew Krowne.
Investment Thesis & Strategy
Dolby Family Ventures invests in various stages of biotech, healthcare, medical devices, SaaS, and security companies. They are looking for promising companies in these sectors.
Portfolio Companies
Selected investments from their portfolio of 56 companies
A
Authentic Vision
Other · Series A, 0
K
Keyssa
Other · Series B, 0
P
PharmatrophiX
Biotech · Seed, 0
E
Echo
Other · Seed, 0
C
CytoVale
Healthcare · Series A, 0
P
Paradromics
Healthcare · Series A, 0
T
TripleBlind
Cybersecurity · Series A, 0
A
Atomwise
AI/ML · Series A, 0
T
Therini Bio
Biotech · Seed, 0
E
Eyefluence
Other · Series A, 0
L
Libra Therapeutics
Biotech · Seed, 0
T
Tetra Discovery
Biotech · Seed, 0
Frequently Asked Questions
Andrew Krowne focuses on Seed stage investments.
Related Investors
Bill Coughran
San Francisco, United States · 104 deals
Dave Lambert
San Francisco, United States · 101 deals
Arun Mathew
San Francisco, United States · 99 deals
Ash Rust
San Francisco, United States · 96 deals
Alex Tran
San Francisco, United States · 95 deals
Randy Williams
San Francisco, United States · 95 deals